Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2008
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapyGema Mateo, M Angeles Montalbán, Maria-Belén Vidriales, et al.
Bone Marrow Transplantation|June 10, 2022
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemiaLorenzo Lazzari, Aitana Balaguer-Roselló, Juan Montoro, et al.
Haematologica|April 26, 2015
Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trialMaría-Victoria Mateos, Albert Oriol, Laura Rosiñol, et al.
NPJ Precision Oncology|January 7, 2026
Optical genome mapping as a high-resolution tool for uncovering cytogenetic complex and cryptic alterations in a cohort of patients with MDS and AMLNeus Torres-Hernández, Elvira Mora, Cristian García-Ruiz, et al.
Transplantation and Cellular Therapy|October 18, 2024
Gastric Bleeding in Stem Cell Transplantation: A Focus on Gastric Vascular Ectasia Under Post-Transplant Cyclophosphamide, Sirolimus, and Mycophenolate Mofetil ProphylaxisJuan Eirís, Juan Montoro, Marta Villalba, et al.
Annals of Hematology|October 13, 2021
Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab eraJulio Del Río-Garma, Sabela Bobillo, Javier de la Rubia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Effect of CD8⁺ cell content on umbilical cord blood transplantation in adults with hematological malignanciesFederico Moscardó, Jaime Sanz, Francisco Carbonell, et al.
Hematological Oncology|September 9, 2016
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism arrayRamón García-Sanz, Luis Antonio Corchete, Miguel Alcoceba, et al.
Haematologica|July 29, 2010
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 studyJuan José Lahuerta, Maria Victoria Mateos, Joaquin Martínez-López, et al.
Hemasphere|July 11, 2020
Results of an Early Access Treatment Protocol of Daratumumab Monotherapy in Spanish Patients With Relapsed or Refractory Multiple MyelomaAdrián Alegre, Javier de la Rubia, Anna Sureda Balari, et al.
Pageof 20